| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 03/09/2011 | EP2292666A2 Neoplasm specific antibodies and uses thereof |
| 03/09/2011 | EP2292665A1 Use of interleukin-4 antagonists and compositions thereof |
| 03/09/2011 | EP2292664A2 Multispecific deimmunized CD3-binders |
| 03/09/2011 | EP2292663A2 Antagonistic human light-specific human monoclonal antibodies |
| 03/09/2011 | EP2292662A2 Assay and reagents for quantifying hBNP |
| 03/09/2011 | EP2292661A2 Interleukin-10 antibodies |
| 03/09/2011 | EP2292660A2 Human antibody molecules for IL-13 |
| 03/09/2011 | EP2292659A1 Anti-perspiration antigen monoclonal antibody |
| 03/09/2011 | EP2292658A2 Novel immunoadhesins for treating and preventing toxicity and pathogen-mediated diseases |
| 03/09/2011 | EP2292655A1 Peptides and related molecules that bind to tall-1 |
| 03/09/2011 | EP2292654A2 A lymphocyte surface receptor that binds CAML, nucleic acids encoding the same and methods of use thereof |
| 03/09/2011 | EP2292652A2 Interferons uses and compositions related thereto |
| 03/09/2011 | EP2292651A1 Methods and compositions for the prevention and treatment of anemia |
| 03/09/2011 | EP2292650A1 Methods and compositions for the prevention and treatment of anemia |
| 03/09/2011 | EP2292643A1 Replikin peptides and uses thereof |
| 03/09/2011 | EP2292637A2 Process for protein extraction |
| 03/09/2011 | EP2292631A1 Regeneration of endogenous myocardial tissue by induction of neovascularization |
| 03/09/2011 | EP2292301A2 Anti-interferon-alpha antibodies |
| 03/09/2011 | EP2292273A2 Remodeling and glycoconjugation of peptides |
| 03/09/2011 | EP2292271A2 Remodelling and glycoconjugation of an antibody |
| 03/09/2011 | EP2292265A1 Set of antiangiogenic molecules and use thereof |
| 03/09/2011 | EP2292264A2 Methods and compositions for increasing the efficiency of therapeutic antibodies using NK cell potentiating compounds |
| 03/09/2011 | EP2292259A2 Complement receptor 2 targeted complement modulators |
| 03/09/2011 | EP2292250A1 Methods of vaccine administration, new feline caliciviruses, and treatments for immunizing animals against feline parvovirus and feline herpes virus |
| 03/09/2011 | EP2292248A2 Anti-angiogenic compounds |
| 03/09/2011 | EP2292247A2 Immunizing composition and method for inducing an immune response against the beta-secretase cleavage site of amyloid precursor protein |
| 03/09/2011 | EP2291536A2 Anti-psgl-1 antibodies and methods of identification and use |
| 03/09/2011 | EP2291406A1 An anti-cancer cytotoxic monoclonal antibody |
| 03/09/2011 | EP2291405A1 ANTI-PirB ANTIBODIES |
| 03/09/2011 | EP2291404A1 Antibodies to il-6 and their uses |
| 03/09/2011 | EP2291403A1 Treatment of chronic prostatitis |
| 03/09/2011 | EP2291402A2 Antibodies against domains of laminin-332 |
| 03/09/2011 | EP2291401A2 Antagonists of bmp9, bmp10, alk1 and other alk1 ligands, and uses thereof |
| 03/09/2011 | EP2291400A1 Method of diagnosis of infection by mycobacteria and reagents therefor |
| 03/09/2011 | EP2291399A2 Multivalent fibronectin based scaffold domain proteins |
| 03/09/2011 | EP2291398A1 Her3 as a determinant for the prognosis of melanoma |
| 03/09/2011 | EP2291395A1 Novel and powerful mhc-class ii petptides derived from survivin |
| 03/09/2011 | EP2291394A1 Fusion proteins and their use in the diagnosis and treatment of leishmaniasis |
| 03/09/2011 | EP2291196A2 Staphylococcus aureus-specific antibody preparations |
| 03/09/2011 | EP1749029B1 Binding molecules capable of neutralizing rabies virus and uses thereof |
| 03/09/2011 | EP1732602B1 Detecting the mcsp-surface expression of a cell |
| 03/09/2011 | EP1709080B1 ANTIBODIES TO MAdCAM |
| 03/09/2011 | EP1708961B1 Anti-ip-10 antibodies |
| 03/09/2011 | EP1594548B1 Anthracycline-anti-cd74 antibody conjugates |
| 03/09/2011 | EP1583558B1 Designed deimmunized monoclonal antibodies for protection against hiv exposure and treatment of hiv infection |
| 03/09/2011 | EP1364963B1 A novel natural antibacterial peptide, the nucleotide sequence encoding it and the use thereof |
| 03/09/2011 | EP1355918B1 Recombinant protective protein from $i(streptococcus pneumoniae) |
| 03/09/2011 | EP1276887B1 Protection against environmental toxicity through manipulation of the processing of messenger rna precursors |
| 03/09/2011 | EP1181320B1 Somatic transgene immunization and related methods |
| 03/09/2011 | CN101983972A Preparation method of anti-sulfanilamide rabbit monoclonal antibody and application thereof |
| 03/09/2011 | CN101983971A Preparation method of anti-fluoroquinolone rabbit monoclonal antibody and application thereof |
| 03/09/2011 | CN101983970A Anti-DON single-chain antibody ScFv and preparing method and application thereof |
| 03/08/2011 | US7902488 Microwave-assisted peptide synthesis |
| 03/08/2011 | US7902441 Group of recessive oncogenes, Fus1, 101F6, Gene 21 (NPRL2), Gene 26 (CACNA2D2), Luca 1 (HYAL1), Luca 2 (HYAL2), PL6 ,123F2 (RaSSFI), SEM A3 and Beta* (BLU), defined by homozygous deletion in lung cancer, have been located, isolated at 3p21.3 |
| 03/08/2011 | US7902349 Nucleic acids encoding protective epitopes of adenyl cyclase-haemolysin (AC-Hly) |
| 03/08/2011 | US7902348 Janus family kinases and identification of immune modulators |
| 03/08/2011 | US7902344 Nucleotide sequences coding antibody specific for bacillus anthracis antigen for use in diagnosis, prevention and treatment of anthrax exposure; immunotherapy |
| 03/08/2011 | US7902340 Antibodies binding to the extracellular domain of the receptor tyrosine kinase ALK |
| 03/08/2011 | US7902339 Monoclonal antibody which binds fetal thymocytes, inhibitits cell proliferation and does not bind adult thymocytes; for use in treatment and prevention of cell proliferative disorders; immunotherapy |
| 03/08/2011 | US7902338 Anti-CD19 antibodies |
| 03/08/2011 | US7902334 Pesticidally active proteins and polynucleotides obtainable from Paenibacillus species |
| 03/08/2011 | US7902329 Oligopeptide tyrosinase inhibitors and uses thereof |
| 03/08/2011 | US7902328 Amyloid β(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereof |
| 03/08/2011 | US7902151 Methods and compositions for modulating immunity |
| 03/08/2011 | US7901917 Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis |
| 03/08/2011 | US7901908 Cell comprising vector coding stabilizing anti-repressor (STAR) sequences and bicistronic gene sequences for improving expression of heterologus gene |
| 03/08/2011 | US7901900 quantitatively or qualitatively determine human low molecular weight CD14 with high sensitivity and specificity in a simple manner |
| 03/08/2011 | US7901894 Kinase inhibitors |
| 03/08/2011 | US7901892 Methods and compositions for determining the purity of chemically synthesized nucleic acids |
| 03/08/2011 | US7901689 Chimeric peptides as immunogens, antibodies thereto, and methods for immunization using chimeric peptides or antibodies |
| 03/08/2011 | US7901686 drug screening; reaction mixture includes a hedgehog polypeptide, a patched polypeptide, and a test compound; receptor binding assay |
| 03/08/2011 | US7901685 Methods for assaying inhibition of HIV-1 envelope glycoprotein-mediated membrane fusion |
| 03/08/2011 | US7901684 Antibodies against human IL-22 and uses therefor |
| 03/08/2011 | US7901683 Methods of inhibiting amyloid toxicity |
| 03/08/2011 | US7901682 Compositions and methods for the treatment and prevention of cancer, angiogenesis, and inflammation |
| 03/08/2011 | US7901681 Trypanosome derived apoptotic factors (TAF) |
| 03/08/2011 | US7901680 Dock-and-lock (DNL) vaccines for cancer therapy |
| 03/08/2011 | US7901679 Humanized anti-ghrelin antibodies |
| 03/08/2011 | US7901678 Medicinal compositions containing Fc receptor γ chain activator |
| 03/08/2011 | CA2468415C Non-human animal model of systemic lupus erythematosus |
| 03/08/2011 | CA2422291C Targeted alpha particle therapy using actinium-225 conjugates |
| 03/08/2011 | CA2366559C Protein isolation and analysis |
| 03/08/2011 | CA2240516C Novel tyrosine kinase receptors and ligands |
| 03/03/2011 | WO2011026132A2 Methods and compositions for the inhibition of transplant rejection |
| 03/03/2011 | WO2011026122A2 B7-h4 fusion proteins and methods of use thereof |
| 03/03/2011 | WO2011025964A2 Therapeutic dll4 binding proteins |
| 03/03/2011 | WO2011025962A1 Antikine antibodies that bind to multiple cc chemokines |
| 03/03/2011 | WO2011025883A2 Natural igm antibodies |
| 03/03/2011 | WO2011025826A1 Methods for creating antibody libraries |
| 03/03/2011 | WO2011025394A1 Complete genome sequence of the methanogen methanobrevibacter ruminantium |
| 03/03/2011 | WO2011024887A1 Conjugate containing cyclic peptide and method for producing same |
| 03/03/2011 | WO2011024748A1 Modified peptide vaccine derived from influenza m2 |
| 03/03/2011 | WO2011024114A1 Targeting extracellular matrix molecules for the treatment of cancer |
| 03/03/2011 | WO2011024113A1 Methods for treating visceral pain by administering antagonist antibodies directed against calcitonin gene-related peptide |
| 03/03/2011 | WO2011023787A1 Affinity-matured humanized anti cea monoclonal antibodies |
| 03/03/2011 | WO2011023785A1 Targeting tissue factor to activated platelets |
| 03/03/2011 | WO2011023705A1 Production of monoclonal antibodies in vitro |
| 03/03/2011 | WO2011023623A1 Velocity factor |
| 03/03/2011 | WO2011023522A1 Antibody fusion-mediated plant resistance against oomycota |
| 03/03/2011 | WO2011023390A1 Antibodies against cdcp1 for the treatment of cancer |